🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Heading to CSANZ in Perth tomorrow? 🫀 We've rounded up the presentations from the Victorian Heart Hospital and Monash Victorian Heart Institute so you know where and when to cheer on our Monash University and Monash Health cohort over the next few days! Celebrate them here: bit.ly/4fpg21m

Did you know more than 80% of strokes can be prevented? 🧠❤️‍🩹 This #NationalStrokeWeek know the FAST signs of stroke so you can save a life. Learn the signs and meet the Monash University School of Clinical Sciences Monash Victorian Heart Institute masters of stroke: bit.ly/3AazoHx

Constipation may be a significant risk factor for heart attacks and strokes, says a study led by Professor Prof Francine Marques. Could your gut health be the key to preventing heart disease? Read: bit.ly/3X1bupI #Cardiology #GutHealth #MonashUniversity

Did you know cardiovascular diseases are a leading cause of death among Australian women, claiming around 20 lives every day? This #WomensHealthWeek, cardiologist and researcher Dr Esther Davis, shares 5 actions you can take to protect your heart. Read: mona.sh/NeFo50TeZEm

Around 120 people die in Australia each day from cardiovascular disease. The good news is that many of the key risk factors are preventable ♥️ On #WorldHeartDay, Steve Nicholls, shares his top tips to help you take charge of your heart health. Watch: bit.ly/3XV47ld

Don’t miss the Personalised Medicine Pitch Event on Oct 22 at the Victorian Heart Hospital! 🌟 Keynote: Prof Reilly (Columbia University) 💡 Pitch Presenters: Hear from six innovators 🏆 Prizes 🤝 Networking & collaboration Register 👉 bit.ly/48blG3L

It was a privilege to present the findings of the KRAKEN and BROOKLYN trials at #AHA24 today on behalf of two incredible teams and the patients who play an important role in advancing treatments for heart disease ⁦Monash Victorian Heart Institute⁩ ⁦NewAmsterdam Pharma Corporation⁩ ⁦Eli Lilly and Company⁩

JAMA Cardiology Muvalaplin produced substantial reductions in lipoprotein(a) levels in patients at high risk of cardiovascular events. #AHA24 ja.ma/4fzIjCc

Victorian Heart Institute and Hospital Director Steve Nicholls is leading world-first trials for genetic high cholesterol, expanding potentially life-saving treatments for those at risk of heart attack and stroke, presented at American Heart Association. Read: bit.ly/3Zf4IyK

As we explore #LivingWell, new research from Dr Barbara R Cardoso reveals that Ultra-Processed Foods are accelerating our biological aging. For every 10% increase in UPF consumption, biological age jumps by 2.4 months. Read: bit.ly/41uW40z

Meet our newly appointed Deputy Directors! Prof Prof Francine Marques (Discovery), A/Prof Nitesh Nerlekar (Clinical Research), and Prof Dominique Cadilhac (Health Systems) will provide strategic direction and research expertise across the translational spectrum. More: bit.ly/3DovMmX

Clinical trials should be designed with the people they impact most. That’s why the PUMA trial team brought together patients, community members and healthcare professionals for a Community Co-Design Symposium at the Victorian Heart Hospital. Read more: bit.ly/3XIaKGV

In just two years, the Victorian Heart Hospital has saved 20,000+ lives ❤️ A Herald Sun anniversary feature highlights the impact of integrating care, research and education at VHH - home to the Monash Victorian Heart Institute. Read online: bit.ly/3RfaCLm

Exciting day with more obicetrapib data for at ⁦⁦European Atherosclerosis Society⁩ with publications in ⁦NEJM⁩ and ⁦The Lancet⁩ ⁦John Kastelein⁩ ⁦Prof Kausik Ray FMedSci⁩ ⁦Michael Davidson MD⁩ ⁦Adam Nelson⁩ ⁦Julie Butters⁩ ⁦Monash Victorian Heart Institute⁩ ⁦NewAmsterdam Pharma Corporation⁩

This #HeartWeek, we're sharing new hope for those at high risk of heart attack and stroke 🫀 The BROADWAY trial shows new pill Obicetrapib reduces LDL cholesterol and Lp(a) by over 30%. “It could be a game-changer,” says Steve Nicholls. 🔗 Read: bit.ly/3SscPUl

Congratulations to Monash Victorian Heart Institute and NewAmsterdam Pharma Corporation for winning Clinical Partnership of the Year at #CitelineAwards 2025! Their global trial of obicetrapib involved 12,000+ patients in 23 countries, setting new standards for academic–industry collaboration: mona.sh/2v3Y50VWQPg

New analysis from the Monash Victorian Heart Institute led HUYGENS study shows patients with high Lp(a) benefit most from evolocumab on top of statin therapy after a heart attack 🫀 ➡️ Read the study: bit.ly/3FmCye9

How can a high-fibre shake protect your heart? ♥️ New Monash University research from Prof Francine Marques lab shows SCFAs - produced when gut bugs digest fibre - activate receptors that cut cardiovascular risk by 20%. Read: bit.ly/43IRTxw